Most cited papers from Illinois CancerCare

Illinois CancerCare

What are the most cited papers from Illinois CancerCare?

The most cited paper from Illinois CancerCare is "Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial" (David N. Krag, Stewart Anderson, Thomas B. Julian et al., 2010), with 1,949 citations. Next come "Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial" (872) and "Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study" (589).

Published TypeFieldAccessCitations

Showing 50 of 56 papers. Every paper with more than 82 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology Open access	Oct 2010	1,949
2	Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial David J. Kuter et al. · The Lancet	Feb 2008	872
3	Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study Sant P. Chawla, Robert Mikael Henshaw, Leanne L. Seeger et al. · The Lancet Oncology	15 Jul 2013	589
4	First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Linda M. Liau et al. · Journal of Translational Medicine Open access	25 May 2018	547
5	Role of toll-like receptor signalling in A uptake and clearance Keishiro Tahara, Hong-Duck Kim, Jipeng Jin et al. · Brain Open access	19 Sep 2006	496
6	Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134 Michael B. Atkins et al. · Journal of Clinical Oncology Open access	27 Sep 2022	474
7	Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting Rudolph M. Navari, Rui Qin, Kathryn J. Ruddy et al. · New England Journal of Medicine Open access	14 Jul 2016	455
8	Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma Linda M. Liau et al. · JAMA Oncology Open access	17 Nov 2022	451
9	Cathepsin B as a cancer target Christopher S. Gondi, Jasti Sambasiva Rao · Expert Opinion on Therapeutic Targets Open access	8 Jan 2013	397
10	Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study Giorgio V. Scagliotti, Vera Hirsh, Salvatore Siena et al. · Journal of Thoracic Oncology Open access	15 Nov 2012	340
11	Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial Shaji Kunnathu Kumar et al. · The Lancet Oncology Open access	29 Aug 2020	263
12	A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA Debra L. Barton, Edward J. Wos, Rui Qin et al. · Supportive Care in Cancer Open access	24 May 2010	255
13	Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans Robert G. Maki, Rashid A. Awan, Richard H. Dixon et al. · International Journal of Cancer	30 Jul 2002	254
14	Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188) Nancy E. Davidson, Anne O’Neill, Allen M. Vukov et al. · Journal of Clinical Oncology	9 Aug 2005	226
15	Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma Daniel J. Olson, Zeynep Eroglu, Bruce Brockstein et al. · Journal of Clinical Oncology Open access	4 May 2021	223
16	Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium Sonali M. Smith, Koen van Besien, Theodore G Karrison et al. · Journal of Clinical Oncology Open access	14 Sep 2010	210
17	The results of conservative management of juvenile osteochondritis dissecans using joint scintigraphy Bernard R. Cahill, Mark Phillips, Ronald Anthony Navarro · The American Journal of Sports Medicine	Sep 1989	208
18	Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy Delvyn Caedren Case, R. M. Bukowski, Robert W. Carey et al. · JNCI Journal of the National Cancer Institute	19 May 1993	201
19	Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer Russell Zelig Szmulewitz, Cody J. Peer, Abiola Falilat Ibraheem et al. · Journal of Clinical Oncology Open access	28 Mar 2018	182
20	Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling Alexa Betzig Schrock et al. · Journal of Thoracic Oncology Open access	16 Mar 2017	174
21	Speech and Swallowing Function After Anterior Tongue and Floor of Mouth Resection With Distal Flap Reconstruction Barbara Roa Pauloski, Jeri A. Logemann, ALFRED W. RADEMAKER et al. · Journal of Speech Language and Hearing Research	Apr 1993	173
22	A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179 Greg Andrew Durm, Salma K. Jabbour, Sandra K. Althouse et al. · Cancer Open access	22 Jul 2020	169
23	Speech and Swallow Function After Tonsil/Base of Tongue Resection With Primary Closure Jeri A. Logemann, Barbara Roa Pauloski, ALFRED W. RADEMAKER et al. · Journal of Speech Language and Hearing Research	Oct 1993	145
24	Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer Jeffrey A. Meyerhardt et al. · JAMA Open access	6 Apr 2021	137
25	Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial Joel W. Neal, Suzanne Eleanor Dahlberg, Heather A. Wakelee et al. · The Lancet Oncology Open access	4 Nov 2016	135
26	Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation Timothy S. Fenske et al. · British Journal of Haematology Open access	15 Mar 2016	134
27	The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type Leora Witkowski, Catherine Goudie, Pilar Ramos et al. · Gynecologic Oncology Open access	19 Mar 2016	134
28	A Contextual-Moderator Analysis of Emotional Autonomy and Adjustment in Adolescence Teresa Fuhrman, Grayson N. Holmbeck · Child Development	Jun 1995	133
29	Proteases and Glioma Angiogenesis Sajani S. Lakka, Christopher S. Gondi, Jasti Sambasiva Rao · Brain Pathology Open access	Oct 2005	129
30	Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With AdvancedEGFR-Mutant Non–Small Cell Lung Cancer Thomas E. Stinchcombe, Pasi Antero Janne, Xiaofei Wang et al. · JAMA Oncology Open access	8 Aug 2019	128
31	Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆ Romain Cohen, Q. Shi, J. P. Meyers et al. · Annals of Oncology Open access	20 Jul 2021	126
32	Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial Nitin Jain et al. · Clinical Cancer Research Open access	Nov 2013	115
33	Axonal Remyelination by Cord Blood Stem Cells after Spinal Cord Injury Venkata Ramesh Dasari, Daniel G. Spomar, Christopher S. Gondi et al. · Journal of Neurotrauma Open access	Feb 2007	115
34	A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503 Anne M. Traynor, Ju-Whei Lee, Gerald K. Bayer et al. · Investigational New Drugs Open access	23 Feb 2009	111
35	Tumor response and progression‐free survival as potential surrogate endpoints for overall survival in extensive stage small‐cell lung cancer Nathan R. Foster, Yingwei Qi, Qian Shi et al. · Cancer Open access	19 Oct 2010	111
36	Can a Controlled-Release Oral Dose Form of Oxycodone Be Used as Readily as an Immediate-Release Form for the Purpose of Titrating to Stable Pain Control? Robert T. Salzman, Michael Stephen Roberts, James E. Wild et al. · Journal of Pain and Symptom Management Open access	Oct 1999	109
37	Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial Ying Guo, Desirée Jones, J. Lynn Palmer et al. · Supportive Care in Cancer Open access	20 Dec 2013	107
38	Recovery of postoperative swallowing in patients undergoing partial laryngectomy ALFRED W. RADEMAKER, Jerl A. Logemann, Barbara Roa Pauloski et al. · Head & Neck	Jul 1993	107
39	Toward the development of a play performance scale for children (PPSC) Lester L. Lansky, Marcy A. List, Shirley B. Lansky et al. · Cancer	Oct 1985	107
40	An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications. Simon J Park, Chase P. Smith, Ryan R. Wilbur et al. · PubMed Open access	2018	106
41	A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia Halla Sayed Nimeiri, Amit M. Oza, Robert J. Morgan et al. · Gynecologic Oncology Open access	2 Feb 2010	103
42	Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study Jinxing Li, Beth Elisa Juliar, Constantin Theodore Yiannoutsos et al. · Journal of Clinical Oncology	18 Feb 2005	102
43	Phase II trial of dolastatin-10 in patients with advanced breast cancer Edith A. Perez, David W. Hillman, Paul A. S. Fishkin et al. · Investigational New Drugs	27 Apr 2005	102
44	Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment. Collin M. Labak, Paul Y. Wang, Rishab Arora et al. · PubMed Open access	2016	98
45	A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695) Thomas W. Flaig, Catherine M. Tangen, Siamak Daneshmand et al. · Clinical Cancer Research Open access	10 Feb 2021	97
46	Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603) Roberto Antonio Leon-Ferre, Paul J. Novotny, Eric G. Wolfe et al. · JNCI Cancer Spectrum Open access	18 Oct 2019	94
47	Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression Michelle Sy Go, Jinghong Kou, Jeong-Eun Lim et al. · Biochemical and Biophysical Research Communications Open access	16 Sep 2016	92
48	Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of North Central Cancer Treatment Group protocol N0177 Sunil Krishnan, Paul David Brown, Karla V. Ballman et al. · International Journal of Radiation OncologyBiologyPhysics	20 Apr 2006	91
49	The role of radiotherapy in the management of operable locally advanced breast carcinoma John E. Olson, Donna S Neuberg, Kishan J. Pandya et al. · Cancer	15 Mar 1997	91
50	Phase II Trial of Short-Course CHOP-R Followed by 90Y-ibritumomab Tiuxetan and Extended Rituximab in Previously Untreated Follicular Lymphoma Samuel A. Jacobs, Steven H. Swerdlow, Jeffrey A. Kant et al. · Clinical Cancer Research Open access	Nov 2008	90

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.